-+ 0.00%
-+ 0.00%
-+ 0.00%

Profound Medical Q4 Earnings Assessment

Benzinga·03/05/2026 21:30:08
Listen to the news

Profound Medical (NASDAQ:PROF) reported its Q4 earnings results on Thursday, March 5, 2026 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Profound Medical missed estimated earnings by 0.0%, reporting an EPS of $-0.27 versus an estimate of $-0.27.

Revenue was up $1.80 million from the same period last year.

Earnings History Overview

Last quarter the company beat on EPS by $0.12 which was followed by a 7.87% increase in the share price the next day.

Here's a look at Profound Medical's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.38 -0.41 -0.28 -0.3
EPS Actual -0.26 -0.52 -0.36 -0.2
Revenue Estimate 7.08M 4.02M 4.78M 4.20M
Revenue Actual 5.29M 2.21M 2.62M 4.18M

To track all earnings releases for Profound Medical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.